cefoxitin and Hypercalcemia

cefoxitin has been researched along with Hypercalcemia* in 2 studies

Reviews

1 review(s) available for cefoxitin and Hypercalcemia

ArticleYear
    Psychotherapeut, 2022, Volume: 67, Issue:2

    International studies could already prove a correlation between alexithymia and expressive suppression. This relationship has only been marginally considered in the German literature so far. The prioritized aim of the present study was to investigate a correlative and factorial relationship between alexithymia and expressive suppression.. A total of 317 persons participated in an online survey. Data on alexithymia and expressive suppression were collected using the German versions of the Toronto alexithymia scale (TAS-26) and the emotion regulation questionnaire (ERQ).. The results indicate that the TAS-26 scales in the components "difficulty in identifying feelings" and "difficulty in describing feelings" and the ERQ scale "suppression" in the component of "expressive suppression" have a common construct, which is referred to with the term speechlessness.. The online version contains supplementary material available at 10.1186/s40623-021-01518-w.. Even though the present study confirmed expected differences in complications and morbidity, it suggested that oncoplastic surgery is oncologically safe. Patients undergoing NSM/SSM should be followed closely to allow early detection and treatment of frequently associated complications and ensure timely start of adjuvant therapy.

    Topics: Acacia; Acute Disease; Adaptive Immunity; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Animals, Newborn; Anti-Bacterial Agents; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Biofilms; Biomarkers; Child; Child, Preschool; CRISPR-Cas Systems; Cytokines; Escherichia coli; Female; Gene Expression Profiling; Gene Knockout Techniques; Humans; Hypercalcemia; Hyperoxia; I-kappa B Kinase; Immunity, Cellular; Infant; Infant, Newborn; Inflammation; Interleukin-1 Receptor-Like 1 Protein; Interleukin-13; Kidney; Macrophage Activation; Macrophages; Male; Membrane Transport Modulators; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Middle Aged; Mutation; NF-kappa B p50 Subunit; Oxidative Stress; Pancreatitis; Phenotype; Plant Bark; Plant Extracts; Plant Stems; RNA-Seq; Severity of Illness Index; Sodium-Phosphate Cotransporter Proteins, Type IIa; Sodium-Phosphate Cotransporter Proteins, Type IIc; Staphylococcus aureus; THP-1 Cells; Toll-Like Receptors; Transcription Factor RelA; Transcriptome; Vitamin D3 24-Hydroxylase; Young Adult

2022

Other Studies

1 other study(ies) available for cefoxitin and Hypercalcemia

ArticleYear
Hypercalcaemia secondary to disseminated Mycobacterium abscessus and Mycobacterium fortuitum.
    The journal of the Royal College of Physicians of Edinburgh, 2019, Volume: 49, Issue:3

    The incidence and prevalence of nontuberculous mycobacteria (NTM) infection is on the rise with many cases still going unreported. Given the vague and nonspecific clinical features of NTM infections, it is often missed or mistaken for Mycobacterium tuberculosis. The presumption that NTM infections are benign and do not contribute to morbidity no longer holds true. NTM infections need to be considered in patients with disseminated multisystem disease and in those not responding to standard M. tuberculosis treatment. As NTM infection is associated with granuloma formation, it can result in hypercalcaemia. Interestingly, there is evidence that there may be other mechanisms in play contributing to hypercalcaemia besides the increased calcitriol levels.

    Topics: Aged; Anti-Bacterial Agents; Antibodies; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Granuloma; Humans; Hypercalcemia; Interferons; Liver; Macrophage Colony-Stimulating Factor; Mycobacterium abscessus; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Singapore

2019